Health status instruments for patients with COPD in pulmonary rehabilitation: Defining a minimal clinically important difference

npj Primary Care Respiratory Medicine

Volumn 26, Issue , 2016, Pages

  Alma, Harma ^a   De Jong, Corina ^a   Jelusic, Danijel ^b   Wittmann, Michael ^b   Schuler, Michael ^c   Flokstra De Blok, Bertine ^a   Kocks, Janwillem ^a   Schultz, Konrad ^b   Van Der Molen, Thys ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Klinik Bad Reichenhall   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSESSMENT TEST; CLINICAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE QUESTIONNAIRE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PULMONARY REHABILITATION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE ASSESSMENT; SECONDARY ANALYSIS; ST. GEORGE RESPIRATORY QUESTIONNAIRE; THERAPY EFFECT; PATHOPHYSIOLOGY; PATIENT-REPORTED OUTCOME; RESPIRATORY CARE;

FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; PATIENT REPORTED OUTCOME MEASURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SURVEYS AND QUESTIONNAIRES;

EID: 84986268030     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2016.41     Document Type: Article

References (33)

1. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2012).
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2016; Available at http://www.goldcopd.org/uploads/users/files/GOLD-Report%202016.pdf. Accessed on 7 January 2016.
3. Westwood, M. et al. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir. Res. 12, 40 (2011).
4. van der Molen, T. et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual. Life Outcomes 1, 13 (2003).
5. Jones, P. W. et al. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 34, 648-654 (2009).
6. Jones, P. W., Quirk, F. H. & Baveystock, C. M. The St George's Respiratory Questionnaire. Respir. Med. 85, 25-31 (1991).
7. Jaeschke, R., Singer, J. & Guyatt, G. H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin. Trials 10, 407-415 (1989).
8. Copay, A. G., Subach, B. R., Glassman, S. D., Polly, D. W. Jr & Schuler, T. C. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J. 7, 541-546 (2007).
9. Lydick, E. & Epstein, R. S. Interpretation of quality of life changes. Qual. Life Res. 2, 221-226 (1993).
10. Revicki, D., Hays, R. D., Cella, D. & Sloan, J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J. Clin. Epidemiol. 61, 102-109 (2008).
11. Norman, G. R., Sloan, J. A. & Wyrwich, K. W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med. Care 41, 582-592 (2003).
12. Wyrwich, K. W, Nienaber, N. A., Tierney, W. M. & Wolinsky, F. D. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med. Care 37, 469-478 (1999).
13. Beaton, D. E, Boers, M. & Wells, G. A. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr. Opin. Rheumatol. 14, 109-114 (2002).
14. Curtis, J. R. & Patrick, D. L. The assessment of health status among patients with COPD. Eur. Respir. J. Suppl. 41, 36s-45s (2003).
15. Revicki, D. A. et al. Responsiveness and minimal important differences for patient reported outcomes. Health Qual. Life Outcomes 4, 70 (2006).
16. Kocks, J. W. et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir. Res. 7, 62 (2006).
17. Kon, S. S. et al. The Clinical COPD Questionnaire: response to pulmonary rehabilitation and minimal clinically important difference. Thorax 69, 793-798 (2013).
18. Canavan, J. L. et al. Clinical COPD Questionnaire in patients with chronic respiratory disease. Respirology 19, 1006-1012 (2014).
19. Tsiligianni, I. G. et al. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm. Med. 12, 20 (2012).
20. Kon, S. S. et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir. Med. 2, 195-203 (2014).
21. Dodd, J. W. et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 66, 425-429 (2011).
22. Jones, P. W. St. George's Respiratory Questionnaire: MCID. COPD 2, 75-79 (2005).
23. Jones, P. W. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur. Respir. J. 19, 398-404 (2002).
24. Welling, J. B., Hartman, J. E., Ten Hacken, N. H., Klooster, K. & Slebos, D. J. The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD. Eur. Respir. J. 46, 1598-1604 (2015).
25. Schultz K. et al. RIMTCORE study: routine inspiratory muscle training within COPD rehabilitation - a real-life randomized controlled trial. Eur. Respir. J. (submitted).
26. Kamper, S. J., Maher, C. G. & Mackay, G. Global rating of change scales: a review of strengths and weaknesses and considerations for design. J. Man. Manip. Ther. 17, 163-170 (2009).
27. Jones, P. W. Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. Eur. Respir. J. 7, 55-62 (1994).
28. Jones, P. W. & Bosh, T. K. Quality of life changes in COPD patients treated with salmeterol. Am. J. Respir. Crit. Care Med. 155, 1283-1289 (1997).
29. Osman, I. M., Godden, D. J., Friend, J. A., Legge, J. S. & Douglas, J. G. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 52, 67-71 (1997).
30. Redelmeier, D. A., Bayoumi, A. M., Goldstein, R. S. & Guyatt, G. H. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am. J. Respir. Crit. Care Med. 155, 1278-1282 (1997).
31. Schunemann, H. J. et al. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J. Clin. Epidemiol. 56, 1170-1176 (2003).
32. Meguro, M., Barley, E. A., Spencer, S. & Jones, P. W. Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 132, 456-463 (2007).
33. Juniper, E. F., Guyatt, G. H., Willan, A. & Griffith, L. E. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J. Clin. Epidemiol. 47, 81-87 (1994).